Market revenue in 2023 | USD 8.3 million |
Market revenue in 2030 | USD 23.2 million |
Growth rate | 15.9% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50.6% in 2023. Horizon Databook has segmented the Germany 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
The growing adoption of advanced technologies in the country is fueling market growth in Germany. The country is one of the oldest economies and has the most well-developed public healthcare support systems with robust national social health insurance, including marginalized communities, which has improved access to advanced treatment.
Consequently, the opportunity for 3D printing in the country is immense. According to an article by healthcare-in-europe.com, nearly EUR 10 million is spent each year due to noncompliance as a result of inadequate medication and side effects owing to such errors in the country.
Furthermore, key market players are undertaking various strategic initiatives to accelerate market growth. For instance, in February 2020, Merck KGaA partnered with AMCM, a German medical technology company, to perform clinical testing on tablets manufactured using 3D printing. Such factors are likely to propel the growth of 3D printed drugs market in Germany.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into Germany 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account